13G/A filed by Paradigm Biocapital Advisors LP
Paradigm Biocapital Advisors LP and 3 other reporting persons reported 6,053,268 JBIO shares, 9.5% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:12:22 UTC.
- Accession
- 0001104659-26-128317
- Filer
- CIK 1855655
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Stake
- Shares
- 6,053,268
- Percent of class
- 9.5%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.
Read for the filer group Paradigm Biocapital Advisors LP.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | PN | 6,053,268 | 0 | 6,053,268 | 0 | 6,053,268 | 9.5% |
| Paradigm BioCapital Advisors GP LLC | OO | 6,053,268 | 0 | 6,053,268 | 0 | 6,053,268 | 9.5% |
| Senai Asefaw, M.D. | IN | 6,053,268 | 0 | 6,053,268 | 0 | 6,053,268 | 9.5% |
| Paradigm BioCapital International Fund Ltd. | CO | 5,335,522 | 0 | 5,335,522 | 0 | 5,335,522 | 8.4% |